The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial

(2012) V Pfaffenrath et al.   CEPHALALGIA

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

(2012) et al.   CEPHALALGIA

A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine

(2012) Jerome Goldstein et al.   HEADACHE

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]

(2012) S. Holland et al.   NEUROLOGY

Rizatriptan for Treatment of Acute Migraine in Patients Taking Topiramate for Migraine Prophylaxis

(2011) Jeffrey L. Seeburger et al.   HEADACHE

MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

(2011) Sheena K. Aurora et al.   HEADACHE

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders

(2010) Jeffrey L Seeburger et al.   CEPHALALGIA

Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)

(2010) Richard B Lipton et al.   CEPHALALGIA

Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life

(2009) Ninan T. Mathew et al.   HEADACHE

A Randomized, Double Blind, Placebo-Controlled Study of MAP0004 in Adult Patients With Migraine

(2009) Sheena K. Aurora et al.   HEADACHE

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

(2008) PJ Goadsby et al.   CEPHALALGIA